Eurobio Scientific Société anonyme (EPA:ALERS)

EPA:ALERS Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	26.46	21.77	49.3	47.49	92.92	65.1
Short-Term Investments	0.39	1.29	39.73	38.44	9.47	0.46
Cash & Short-Term Investments	26.86	23.07	89.03	85.94	102.39	65.56
Cash Growth	-68.98%	-74.09%	3.60%	-16.07%	56.18%	760.44%
Accounts Receivable	33.93	32.09	26.94	32.78	43.86	51.21
Other Receivables	3.12	3.97	3.74	6.09	8.32	5.52
Receivables	37.05	36.06	30.67	38.87	52.18	56.73
Inventory	29.66	26.92	21.45	21.65	16.29	12.93
Prepaid Expenses	1.39	1.31	1.01	0.57	0.47	-
Other Current Assets	1.76	1.18	1.39	1.53	2.27	-
Total Current Assets	97.7	89.59	143.91	148.69	173.6	135.21
Property, Plant & Equipment	12.06	12.77	12.3	12.66	10.05	9.92
Long-Term Investments	0.1	0.1	3.6	3.6	3.6	0
Goodwill	117.31	118.9	117.71	115.81	18.19	20.93
Other Intangible Assets	1.74	2.1	2.52	1.97	2.29	3.84
Long-Term Deferred Charges	30.07	32.52	32.9	37.2	1.28	1.66
Other Long-Term Assets	-	0	-	-	0	0
Total Assets	259.94	257.17	316.33	330.73	209.87	172.3
Accounts Payable	19.66	19.02	16.82	18.53	16.77	14.24
Accrued Expenses	4.75	6.15	6.07	9.63	6.57	5.21
Current Portion of Long-Term Debt	-	0.73	13.28	13.73	3.68	13.94
Current Portion of Leases	-	2.07	1.8	1.6	1.56	1.5
Current Income Taxes Payable	5.12	5.48	3.56	1.97	6.28	11.54
Current Unearned Revenue	0.18	0.18	0.2	0.44	0.16	0.18
Other Current Liabilities	2.28	2.76	2.64	1.25	1.05	1.39
Total Current Liabilities	31.99	44.15	52.88	57.32	36.11	47.98
Long-Term Debt	11.25	2.86	81.23	94.34	7.01	10.97
Long-Term Leases	5.5	4.12	4.35	3.97	3.44	3.31
Pension & Post-Retirement Benefits	0.57	0.6	0.53	0.59	0.75	0.81
Other Long-Term Liabilities	21.67	26.59	2.17	1.53	1.69	1.38
Total Liabilities	78.42	78.31	141.16	157.75	49	64.45
Common Stock	3.28	3.28	3.5	3.63	3.63	3.63
Additional Paid-In Capital	20.19	20.19	33.57	40.05	40.05	40.05
Comprehensive Income & Other	-0.86	155.38	138.1	129.31	117.19	64.17
Total Common Equity	181.51	178.86	175.17	172.98	160.87	107.85
Shareholders' Equity	181.51	178.86	175.17	172.98	160.87	107.85
Total Liabilities & Equity	259.94	257.17	316.33	330.73	209.87	172.3
Total Debt	16.75	9.77	100.66	113.64	15.69	29.72
Net Cash (Debt)	10.11	13.3	-11.63	-27.7	86.7	35.84
Net Cash Growth	-	-	-	-	141.89%	-
Net Cash Per Share	0.98	1.30	-1.04	-2.44	7.97	3.18
Filing Date Shares Outstanding	10.07	10.03	10.04	10.22	10.85	11.21
Total Common Shares Outstanding	10.07	10.03	10.04	10.22	10.85	11.21
Working Capital	65.71	45.44	91.03	91.37	137.49	87.23
Book Value Per Share	18.03	17.82	17.44	16.92	14.83	9.62
Tangible Book Value	62.47	57.86	54.94	55.21	140.39	83.08
Tangible Book Value Per Share	6.20	5.77	5.47	5.40	12.94	7.41
Buildings	1.86	1.82	1.33	0.88	0.85	0.71
Machinery	17.23	1.09	0.76	1.12	1.12	8.5
Construction In Progress	-	0.05	0.48	0.45	0.01	1.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.